Prepare for your visit

Amy Doyle Sullivan

Family · White Bluff, TN · NPI 1447033360

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$367.60

in general payments reported to CMS, 2019-2025 · $213 in 2025

The $213 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).

Who reported paying

General payments only, top 5 by amount.

Abbvie INC. $143.02
Novo Nordisk INC $97.31
Astrazeneca Pharmaceuticals LP $60.23
Otsuka America Pharmaceutical, INC. $34.07
Exact Sciences Corporation $32.97

Drugs and devices associated with these payments

Qulipta Ubrelvy Ozempic Breztri Rexulti Cologuard Collection Kit Vraylar Airsupra

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Amy Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11479368/amy-doyle-sullivan